Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long AMAT ETF

28.12
+1.084.00%
Post-market: 28.00-0.1205-0.43%19:56 EDT
Volume:293.32K
Turnover:8.25M
Market Cap:44.99M
PE:- -
High:28.82
Open:28.50
Low:27.69
Close:27.04
52wk High:62.00
52wk Low:16.64
Shares:1.60M
Float Shares:1.60M
Volume Ratio:1.22
T/O Rate:18.33%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Hoskinson Plans 'Great Migration' of Cardano Community From X

utoday
·
Jun 12

DeFi Development Corp. to Host X Spaces Event: “DFDV May 2026 Recap & AMA”

GlobeNewswire
·
Jun 11

Texas Cardiac Arrhythmia Institute at St. David's Medical Center to host international conference on complex cardiac arrhythmias

prnewswire
·
May 22

SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System

GlobeNewswire
·
May 18

DeFi Development Corp. to Host X Spaces Event: “DFDV April 2026 Recap & AMA”

GlobeNewswire
·
May 15

Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026

GlobeNewswire
·
May 14

Press Release: QT Imaging Reports First Quarter 2026 Revenue of $6.5 Million

Dow Jones
·
May 13

NASDAQ New 52-Week Highs And Lows

Dow Jones
·
May 11

AMA Group Proposes to Buy Back Nearly 48 Million Shares

MT Newswires Live
·
May 08

Morgans Remains a Buy on Ama Group Limited (AMA)

TIPRANKS
·
Apr 23

AMA Group Posts Lower Fiscal Q3 EBITDA, Higher Revenue, Shares Up 8%

MT Newswires Live
·
Apr 22

AMA Group lifts margins, confirms FY26 guidance and launches buyback plan

TIPRANKS
·
Apr 22

Why Is Plus Therapeutics Stock Gaining Friday?

Benzinga_recent_news
·
Apr 11

Bell Potter Keeps Their Buy Rating on Ama Group Limited (AMA)

TIPRANKS
·
Apr 09

Plus CNSide Cerebrospinal Fluid Tumor Cell Enumeration test gets AMA PLA code

TIPRANKS
·
Apr 07

Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption

GlobeNewswire
·
Apr 07